Avidity biosciences to host virtual investor and analyst event on may 19, 2021

La jolla, calif., may 3, 2021 /prnewswire/ -- avidity biosciences, inc. (nasdaq: rna), a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called antibody oligonucleotide conjugates (aocs™), today announced that it will host a virtual investor and analyst event focused on the company's aoc platform on wednesday, may 19, 2021, from 8:00 a.m.
RNA Ratings Summary
RNA Quant Ranking